Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
阿特珠单抗联合贝伐珠单抗与乐伐替尼一线治疗不可切除肝细胞癌的疗效和安全性比较:倾向评分匹配分析
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-022-00921-x
Niizeki, Takashi; Tokunaga, Takayuki; Takami, Yuko; Wada, Yoshiyuki; Harada, Masaru; Shibata, Michihiko; Nakao, Kazuhiko; Sasaki, Ryu; Hirai, Fumihito; Shakado, Satoshi; Yoshizumi, Tomoharu; Itoh, Shinji; Yatsuhashi, Hiroshi; Bekki, Shigemune; Ido, Akio; Mawatari, Seiichi; Honda, Koichi; Sugimoto, Rie; Senju, Takeshi; Takahashi, Hirokazu; Kuwashiro, Takuya; Maeshiro, Tatsuji; Nakamuta, Makoto; Aratake, Yoshifusa; Yamashita, Tsutomu; Otsuka, Yuichiro; Matsumoto, Shuichi; Sohda, Tetsuro; Shimose, Shigeo; Murotani, Kenta; Tanaka, Yasuhito